Latest Commercialisation News

Brazilian Rare Earths Limited has unveiled breakthrough ore sorting results at its Monte Alto project, achieving over 95% yield and doubling rare earth grades in a single pass. This advancement promises to lower costs and environmental impact while enhancing project economics.

Hammer Metals has submitted a Mining Lease Application for its Orelia North gold deposit in Western Australia, aiming to accelerate development amid a buoyant gold price. Recent drilling results extend mineralisation, supporting resource growth ahead of a planned 2026 upgrade.

GCM Corporation is advancing its commercialisation strategy with multiple prototypes across key global markets and sectors, aiming for revenue in the first half of 2026.

Nimy Resources has dispatched its inaugural shipment of high-grade gallium ore from Western Australia to the United States, marking a significant step in establishing a secure Western supply chain for this critical mineral.

Vitrafy Life Sciences has delivered key milestones in the first half of FY26, including a strategic partnership with IMV Technologies and progress in clinical studies, while maintaining a strong cash position to support its U.S. expansion and product launches.

5E Advanced Materials has successfully closed an oversubscribed US$36 million public offering, positioning itself to advance its boron operations and finalise key commercial contracts.

St George Mining has released a comprehensive investor presentation spotlighting its Araxá Project in Brazil, positioning itself as a major global player in niobium and rare earth elements with significant resource expansion and strategic partnerships underway.

OncoSil Medical Limited has announced a fully underwritten $2 million entitlement offer alongside a $6 million placement to fund its clinical and commercial growth initiatives. The capital raising includes new shares and options, with shareholder approvals pending for certain components.

Sparc Technologies and the Australian Institute for Machine Learning are developing AI-driven software to transform protective coatings corrosion assessment, promising faster, more accurate results for a global market of testing labs.

Imricor Medical Systems has welcomed Oklahoma Heart Institute as the fourth U.S. site in its pivotal VISABL-AFL clinical trial, accelerating patient recruitment and the FDA approval pathway for its MRI-guided cardiac ablation technology.

Memphasys has lodged regulatory submissions for its Felix™ System in Australia and India, following CE Mark approval, while progressing UK market entry under the CE Mark transition framework.

Rhythm Biosciences has secured a multi-year commercial manufacturing agreement with US-based Quansys Biosciences to produce ColoSTAT® reagent kits, paving the way for broader market rollout of its colorectal cancer diagnostic test.